Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

More documents

Recommendations

Info

40-Pollock,R.P.,Tielloud,J.L.,Scharff,M.D.(1984).Monoclonal antibodies.a powerfultool for selectionand analyzing mutations in antigens and antibodies.Ann.Rev.Microbiol.38,389-417. 41-Rana, S.K.,Tamisraha, B.(2008).Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains.Vetrinary Immunology and Immunopathology 122,241-249. 42-Robertson,B.H., Morgan,D.O.,Moore,D.M.(1984).Location of neutralizationng epitopes defined by monoclonal antibodies generated against the outer capsit polypeptide, VP1,of foot-andmouth disease virus A12.Virus Research,1,489-500. 43-Robertson,B.H.,Morgan,D.O.,Moore, D.M.(1984).Location of neutralizing epitopesdefined by monoclonal antibodiesgenerated against to outer capsit polypeptide ,VP1,of foot and mouth disease virus A12.Virus Res.1,489-500. 44-Saiz.J.C.,Gonzales,M.J., Borca, M.V.,Sobrino,F., Moore,D.M.(1991). Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus,defined by neutralization resistant variants.Journal of Virology,May,2518-2524 45-Saiz.J.C.,Gonzales,M.J., Morgan,D.O., Card,J.L., Sobrino,F., Moore.D.M.(1989). Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Research,13,45-60. 46-Samuel,A.R., Knowless,N.J.,Samuel, G.D., Crowther, J.R.,(1991).Evaluetion of trapping ELISA for the differention FMDV strains using monoclonal antibodies.Biological19,229-310. 47-Sanyal,A.,Gurumurthy,C.B.,Venkataraman,R.,Hemadri,D.,Tosh,C.(2003) Antigenic characterization of foot-aand-mouth disease virus serotype Asia-1 field isolates using polyclonal and monoclonal antibodies.Veterinary Microbiology,93,1-11. 48-Sanyal,A.,Venkataraman,R.,Pattnaik,b.(1997).Antigenic features of foot-andmouth disease virus serotype Asia-1 as revealed by monoclonal antibodies and neutralization –escape mutants.Virus Research.50,107-117. 49-Seki,C., Robiolo, B., Periolo, O., Iglesias, M., D’antuono, A., Maredei, E., Barros,V.,Torre, J., Mattion, N. (2008).Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity,purity and viral integrity in commercial virus vaccines using monoclonal antibodies.Veterinary Microbiology-4095;13. 50-Sobrino, F., Davila,M.,Ortin,J.,Domingo,E.(1983).Multiple genetic variants arise in the course of replication of foot and mouth disease virus in cell culture.Virology128,310-318. 51-Sobrino, F.,Palma, E.L., Beck,E.,Davila,M., dela Torre,J.C.,Negro, p.,Villanueva,N.,Ortin,J., Domingo,E.(1986). Fixation of mutations in the viral genome during an outbreak of foot and mouth disease :heterogeneity and rate variations.Gene. 50,149-159. 52-Stave, J.W.,Card, J.L.,Morgan,D.O.(1986).Analysis of foot and disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.J.gen.Virology.67,2083-2092. 53-Stave, J.W.,Card, J.L.,Morgan,D.O.,Vacharia,V.N.(1988). Neutralizations sites of type O1 footand- mouth disease virus defined by monoclonal antibodiess and neutralization-escape virus variants.Virology162,21-29. 54-Sutmoller,P.,Vieira,A.(1980).The relationship of neutralising antibody titers for FMDV and the protectionof cattle.Bol.Cent.Panamer.Fiebre Aftosa, 57,39-40. 55-Thomas,A.A.M.,Worthmeijer, R.J.,Puijk, W.,Barteling, S.J.(1988).Antigenic sites of FMDV type A10.J.Virol.62,2782-89. 56-Van Manen,C. AND Terpstra,C.(1990).Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.Biologicals,18,315-319. 57-Xie,Q.,Mc Cahon, D.,Crowther, J.R.,Belsham,G.J.and Mc Cullough,K.C. (1987). Neutralization of foot and mouth disease virus can be mediated through any of at least three seperate antigenic sites.J.Gen.Virol.68,1637-1647. 58-Yang,M., Clavijo,A., Suarez-Banmann,R., Avalo,R.(2007). Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.Veterinary ��-134. 59-Yang,M., Holland,H., Clavijo,A.(2008). Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and Aand their potential use in quantification of intact virus for vaccine manufacture.Vaccine 26,3377-3382. 318
�� ÖNSÖZ �� A�� Ramon, G., 1924,1925,1926 , Glenny, A.T. ve ark, 1926�� O’Hagan, D.T. ve ark, 2001]. �� de biyobozunabilir adjuvant imaline imkan verecektir. �� el sistemlerinin içsel �� 319
Page 1 and 2:
T.C. ��
Page 3 and 4:
��
Page 5 and 6:
��
Page 7 and 8:
59 ��
Page 9 and 10:
TC ��
Page 11 and 12:
��
Page 13 and 14:
��
Page 15 and 16:
10. OIE -Bovin Tuberculosis Chapter
Page 17 and 18:
7. ��
Page 19 and 20:
��
Page 21 and 22:
13. KAUFMANN, S.H.E., Van Embden, J
Page 23 and 24:
ovine Virus diarrhea virusu (BVDV),
Page 25 and 26:
��
Page 27 and 28:
YILLARA GÖRE ��
Page 29 and 30:
34. ��
Page 31 and 32:
(3) ve Özkul ve ark. (27)� �
Page 33 and 34:
�� : SDS-PAGE
Page 35 and 36:
��
Page 37 and 38:
��
Page 39 and 40:
7-Bishop R.F., Hewstone A.S., David
Page 41 and 42:
TC ��
Page 43 and 44:
1997; Petrovec ve ark., 1999; Aleks
Page 45 and 46:
��
Page 47 and 48:
��
Page 49 and 50:
28-Randall, K., Saiki, B.S., Chu-An
Page 51 and 52:
��
Page 53 and 54:
��
Page 55 and 56:
immuncomb(IC)(9), direk agglutinasy
Page 57 and 58:
TC ��
Page 59 and 60:
��
Page 61 and 62:
5- Aslan V., Tiftik A. M. (1987). 1
Page 63 and 64:
TC ��
Page 65 and 66:
��
Page 67 and 68:
��
Page 69 and 70:
TC ��
Page 71 and 72:
vi) Öte yandan patojen E. coli�
Page 73 and 74:
��
Page 75 and 76:
��
Page 77 and 78:
(verotoxin)-producing Escherichia c
Page 79 and 80:
TC ��
Page 81 and 82:
��
Page 83 and 84:
��
Page 85 and 86:
MS-Primer R (20 pmol/ µl) : 1 µl
Page 87 and 88:
��
Page 89 and 90:
36. Sanei B, Barnes H. J., Vaillanc
Page 91 and 92:
��
Page 93 and 94:
��
Page 95 and 96:
7. Gürtürk K, Ekin I.H, Aksakal A
Page 97 and 98:
��
Page 99 and 100:
Nazal ve konjunktival swap örnekle
Page 101 and 102:
��
Page 103 and 104:
��
Page 105 and 106:
Test samples will be collected rand
Page 107 and 108:
��
Page 109 and 110:
��
Page 111 and 112:
61.8°C’ de 30��
Page 113 and 114:
��
Page 115 and 116:
ve Anti��
Page 117 and 118:
TC ��
Page 119 and 120:
��
Page 121 and 122:
4- Bakonyi, T., Derakhshifar, I., G
Page 123 and 124:
��
Page 125 and 126:
8.3. Materyal ve Metot: 8.3.1 Mater
Page 127 and 128:
��
Page 129 and 130:
TC ��
Page 131 and 132:
Denmark, H.A., Stanford, M.T. 2000
Page 133 and 134:
��
Page 135 and 136:
��
Page 137 and 138:
��
Page 139 and 140:
�� GÜNGÖ
Page 141 and 142:
17. MURPHY, F. A., GIBBS, J. E. P.,
Page 143 and 144:
SUMMARY: The detection and inhibito
Page 145 and 146:
��
Page 147 and 148:
Aprotinin; Serin proteaz tipi enzim
Page 149 and 150:
1. Doel, T. R., Collen, T. (1982):
Page 151 and 152:
environment they live in, or during
Page 153 and 154:
Ayraçlar: ��
Page 155 and 156:
��
Page 157 and 158:
10.2. ��
Page 159 and 160:
TC ��
Page 161 and 162:
��
Page 163 and 164:
Konjugat:� ��
Page 165 and 166:
6. Grotmol S., Todland G.K., (2000)
Page 167 and 168:
TC ��
Page 169 and 170:
��
Page 171 and 172:
��
Page 173 and 174:
��
Page 175 and 176:
25. Sitjà-Bobadilla, A., Alvarez-P
Page 177 and 178:
��
Page 179 and 180:
��
Page 181 and 182:
��
Page 183 and 184:
TC ��
Page 185 and 186:
��
Page 187 and 188:
��
Page 189 and 190:
12. ��
Page 191 and 192:
TC ��
Page 193 and 194:
8.2. Literatür Özeti: ��
Page 195 and 196:
��
Page 197 and 198:
��
Page 199 and 200:
��
Page 201 and 202:
ve mortaliteleri ile bunlar�� e
Page 203 and 204:
��
Page 205 and 206:
��
Page 207 and 208:
��
Page 209 and 210:
��
Page 211 and 212:
��
Page 213 and 214:
��
Page 215 and 216:
Tablo 18 ��
Page 217 and 218:
��
Page 219 and 220:
��
Page 221 and 222:
��
Page 223 and 224:
��
Page 225 and 226:
��
Page 227 and 228:
��
Page 229 and 230:
��
Page 231 and 232:
��
Page 233 and 234:
��
Page 235 and 236:
��
Page 237 and 238:
��
Page 239 and 240:
sonucunda 8’inde (%8) P.larvae�
Page 241 and 242:
14. Dobbelaere, W.D., Graaf de, D.C
Page 243 and 244:
amounts were prepared with current
Page 245 and 246:
��
Page 247 and 248:
��
Page 249 and 250:
3.4.5. Sterilite ��
Page 251 and 252:
��
Page 253 and 254:
Log ELISA 3 2.5 2 1.5 1 0.5 0 1 3 5
Page 255 and 256:
��
Page 257 and 258:
Tablo.9. ��
Page 259 and 260:
Tablo.12. POST-MORTEM MUAYENE PD50
Page 261 and 262:
��
Page 263 and 264:
��
Page 265 and 266:
Hamblin, C., Kitching, R.,P., Donal
Page 267 and 268: adaptation period growth kinetics a
Page 269 and 270: hücrenin serumsuz ortamda üretili
Page 271 and 272: 6M (%2SBP): % 2 soybean pepton, tra
Page 273 and 274: ��
Page 275 and 276: Çizelge.1. ��
Page 277 and 278: ��
Page 279 and 280: Öneriler;��
Page 281 and 282: ��
Page 283 and 284: ��
Page 285 and 286: ��
Page 287 and 288: Grafik-2 SAV-��
Page 289 and 290: ��
Page 291 and 292: ��
Page 293 and 294: Grafik-8 SAV-21 Konsantre antijenin
Page 295 and 296: ��
Page 297 and 298: ��
Page 299 and 300: 22. Lombard M, Füssel AE. (2007):
Page 301 and 302: ��
Page 303 and 304: ��
Page 305 and 306: ��
Page 307 and 308: Deney hayvanlar��
Page 309 and 310: ��
Page 311 and 312: ��
Page 313 and 314: Grafik 4-��
Page 315 and 316: ��
Page 317: 18-��
Page 321 and 322: ��
Page 323 and 324: ��
Page 325 and 326: ��
Page 327 and 328: Toplam BSA kütlesi = film kütlesi
Page 329 and 330: �� Konsantre
Page 331 and 332: 20. Aucouturier, J., Dupuis, L., Ga
Page 333 and 334: ��
Page 335 and 336: ��
Page 337 and 338: 3.2. Metot 3.2.1. Örneklerin Homoj
Page 339 and 340: ��
Page 341 and 342: 18.HOPPER, K., (1989). The isolatio
Page 343 and 344: A SINIFI��
Page 345 and 346: ��
Page 347 and 348: ��
Page 349 and 350: 3.2. Metot ��
Page 351 and 352: Tablo 4��
Page 353 and 354: Summary Listeria monocytogenes was
Page 355 and 356: ��
Page 357 and 358: ��
Page 359 and 360: ��
Page 361 and 362: ��
Page 363 and 364: Yeast extract......................
Page 365 and 366: ��
Page 367 and 368: ��
Page 369 and 370:
Resim 3.3.1. ��
Page 371 and 372:
��
Page 373 and 374:
46. Unestam, T., Weiss, D. W. (1970
Page 375 and 376:
��
Page 377 and 378:
��
Page 379 and 380:
��
Page 381 and 382:
��
Page 383 and 384:
��
Page 385 and 386:
��
Page 387 and 388:
��
Page 389 and 390:
��
Page 391 and 392:
��
Page 393 and 394:
��
Page 395 and 396:
��
Page 397 and 398:
��
Page 399 and 400:
��
Page 401 and 402:
��
Page 403 and 404:
��
Page 405 and 406:
��
Page 407 and 408:
��
Page 409 and 410:
��
Page 411 and 412:
��
Page 413 and 414:
500 bp MW 1 2 3 4 5 6 7 ��
Page 415 and 416:
��
Page 417 and 418:
��
Page 419 and 420:
8.2.Proje Faaliyet Takvimi: ��
Page 421:
49. Dr. Gülhan AYNAGÖZ ��
show all

Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

Create successful ePaper yourself

Delete template?

Save as template?